Thorne Research Overview
- Year Founded
-
1984
- Status
-
Acquired/Merged
- Employees
-
595
- Latest Deal Type
-
M&A
- Financing Rounds
-
11
- Investments
-
11
Thorne Research General Information
Description
Manufacturer of dietary supplements intended for health-care professionals, and athletes. The company utilizes testing and data to create improved product efficacy for improving energy, reducing stress, and improving gut and joint health.
Contact Information
Website
www.thorne.com(Operating Subsidiary)
Corporate Office
- 558 Omni Industrial boulevard and 620 Omni Industrial boulevard
- Summerville, SC 29486
- United States
Corporate Office
- 558 Omni Industrial boulevard and 620 Omni Industrial boulevard
- Summerville, SC 29486
- United States
Thorne Research Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Thorne Research Comparisons
Industry
Financing
Details
Thorne Research Competitors (9)
One of Thorne Research’s 9 competitors is Physician's Choice (Consumer Non-Durables), a Corporation company based in Wheat Ridge, CO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Physician's Choice (Consumer Non-Durables) | Corporation | Wheat Ridge, CO | ||||
| Standard Process | Corporation | Palmyra, WI | ||||
| Xymogen | Venture Capital-Backed | Orlando, FL | ||||
| Ortho Molecular Products | Corporation | Woodstock, IL | ||||
| Metagenics | Private Equity-Backed | Aliso Viejo, CA |
Thorne Research Patents
Thorne Research Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20170014374-A1 | Composition for treatment of dyslipidemia and inflammation | Inactive | 13-Jul-2015 | ||
| US-20080293671-A1 | Combination of polychitosamine and fibrate for the prevention and treatment of hyperlipidemia | Inactive | 28-Sep-2005 | ||
| US-20090028951-A1 | Compositions for oral administration of sustained release glutathione, methods for their production and uses thereof | Inactive | 13-Jul-2005 | ||
| US-20110028429-A1 | Combination of polychitosamine and hmg-coa reductase inhibitor for hyperlipidemia | Inactive | 15-Sep-2004 | ||
| US-20130244973-A1 | Combination of polychitosamine and hmg-coa reductase inhibitor for hyperlipidemia | Inactive | 15-Sep-2004 | A61K31/722 |
Thorne Research Signals
Thorne Research Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Thorne Research Investments & Acquisitions (11)
Thorne Research’s most recent deal was a Merger/Acquisition with PreCon Health for . The deal was made on 11-Jan-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| PreCon Health | 11-Jan-2023 | Merger/Acquisition | Drug Discovery | ||
| Effusio | 28-Feb-2022 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Thorne HealthTech Asia | 13-Jan-2022 | Joint Venture | Other Healthcare Services | ||
| Drawbridge Health | 25-May-2021 | Merger/Acquisition | Diagnostic Equipment | ||
| Onegevity | 25-Feb-2021 | Merger/Acquisition | Other Healthcare Technology Systems |
Thorne Research Exits (1)
Thorne Research’s most recent exit was on 01-Jan-2021 from Kelai Pharmaceutical. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Kelai Pharmaceutical | 01-Jan-2021 | Completed |
|
Thorne Research FAQs
-
When was Thorne Research founded?
Thorne Research was founded in 1984.
-
Where is Thorne Research headquartered?
Thorne Research is headquartered in Summerville, SC.
-
What is the size of Thorne Research?
Thorne Research has 595 total employees.
-
What industry is Thorne Research in?
Thorne Research’s primary industry is Other Consumer Non-Durables.
-
Is Thorne Research a private or public company?
Thorne Research is a Private company.
-
What is the current valuation of Thorne Research?
The current valuation of Thorne Research is .
-
What is Thorne Research’s current revenue?
The current revenue for Thorne Research is .
-
How much funding has Thorne Research raised over time?
Thorne Research has raised $70M.
-
Who are Thorne Research’s investors?
Helsinn Healthcare, Kirin Holdings, L Catterton, MavenHill Capital, and Mitsui & Co are 5 of 7 investors who have invested in Thorne Research.
-
Who are Thorne Research’s competitors?
Physician's Choice (Consumer Non-Durables), Standard Process, Xymogen, Ortho Molecular Products, and Metagenics are some of the 9 competitors of Thorne Research.
-
When was Thorne Research acquired?
Thorne Research was acquired on 31-Oct-2026.
-
Who acquired Thorne Research?
Thorne Research was acquired by Procter & Gamble.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process